Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 50 entries
View as:

Clinical Efficacy of the Product in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06822335 Org: User:
Start: 04/03/23 End: 08/08/23 Due: 08/08/24

EFFICACY and TOLERABILITY of TESTED FORMULA VS. HYDROQUINONE 4% in the TREATMENT of FACIAL MELASMA

Phase: N/A Priority: Normal
NCT ID: NCT06787846 Org: User:
Start: 08/17/23 End: 03/12/24 Due: 03/12/25

Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis

Phase: N/A Priority: Normal
NCT ID: NCT05765461 Org: User:
Start: 12/31/19 End: 11/28/22 Due: 11/28/23

Efficacy of La Roche Posay Routine in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP)

Phase: N/A Priority: Normal
NCT ID: NCT06770127 Org: User:
Start: 02/27/23 End: 10/16/23 Due: 10/16/24

Management of Side-Effects of Anti-Acne Treatment by a Cosmetic Routine

Phase: N/A Priority: Normal
NCT ID: NCT05486910 Org: User:
Start: 04/29/21 End: 07/29/21 Due: 07/29/22

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

Phase: N/A Priority: Normal
NCT ID: NCT05989633 Org: User:
Start: 07/04/22 End: 06/29/23 Due: 06/29/24

Cutaneous Acceptability, Comedogenic Potential and Efficacy of Two Cosmetic Products Used in Synergy

Phase: N/A Priority: Normal
NCT ID: NCT05490537 Org: User:
Start: 01/13/21 End: 11/11/21 Due: 11/11/22

The Benefit of a Deep Cleansing Gel in the Management of Mild to Moderate Truncal Acne

Phase: N/A Priority: Normal
NCT ID: NCT05584150 Org: User:
Start: 10/01/19 End: 11/30/20 Due: 11/30/21

Photoprotection Efficiency with Sunscreen Formulas Under Visible Light Exposure.

Phase: N/A Priority: Normal
NCT ID: NCT06827392 Org: User:
Start: 09/06/16 End: 10/07/16 Due: 10/07/17

Evaluation of the Photoprotection Efficacy with Sunscreen Formulas Under Visible Light Exposure

Phase: N/A Priority: Normal
NCT ID: NCT06803901 Org: User:
Start: 02/04/19 End: 03/22/19 Due: 03/22/20

Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00624676 Org: User:
Start: 01/31/06 End: 08/31/06 Due: 08/31/07

Satisfaction Survey - Cicaplast Mains

Phase: N/A Priority: Normal
NCT ID: NCT05471934 Org: User:
Start: 02/28/14 End: 05/31/14 Due: 05/31/15

Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Phase: N/A Priority: Normal
NCT ID: NCT06320314 Org: User:
Start: 02/19/24 End: 05/22/24 Due: 05/22/25

Evaluation of Cicaplast in Subjects With Skin Irritation

Phase: N/A Priority: Normal
NCT ID: NCT05767333 Org: User:
Start: 10/11/21 End: 06/06/22 Due: 06/06/23

Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins

Phase: N/A Priority: Normal
NCT ID: NCT06253468 Org: User:
Start: 06/14/24 End: 03/31/25 Due: 03/31/26

Evaluate the Photoprotection Efficacy of Sunscreen Formulas Under Visible Light Exposure

Phase: N/A Priority: Normal
NCT ID: NCT06796192 Org: User:
Start: 06/07/17 End: 07/07/17 Due: 07/07/18

Toleriane Ultra Reno in Allergic Subjects With Skin Intolerance to Their Usual Cosmetic

Phase: N/A Priority: Normal
NCT ID: NCT05487937 Org: User:
Start: 05/25/21 End: 09/28/21 Due: 09/28/22

CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS

Phase: N/A Priority: Normal
NCT ID: NCT05783453 Org: User:
Start: 12/20/21 End: 07/22/22 Due: 07/22/23

Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05644691 Org: User:
Start: 10/14/20 End: 07/14/21 Due: 07/14/22

Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01577628 Org: User:
Start: 06/30/12 End: 02/28/13 Due: 02/28/14

Efficacy of a Deep Cleansing Gel Containing 2% Salicylic Acid, 0.2% Zinc Gluconate and 0.05% Lipohydroxy Acid in the Management of Mild to Moderate Facial Acne

Phase: N/A Priority: Normal
NCT ID: NCT05779085 Org: User:
Start: 04/08/13 End: 07/22/13 Due: 07/22/14

Anti-aging Repairing Serum: Efficacy and Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT06059274 Org: User:
Start: 03/14/18 End: 06/07/18 Due: 06/07/19

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

Phase: N/A Priority: Normal
NCT ID: NCT05469880 Org: User:
Start: 10/21/09 End: 05/25/10 Due: 05/25/11

M89PF in Rosacea Associated With Erythema and Sensitive Skin

Phase: N/A Priority: Normal
NCT ID: NCT05562661 Org: User:
Start: 01/02/21 End: 02/28/21 Due: 02/28/22

Evaluation of Effaclar Duo+M on Acne Lesions in Subjects With Mild to Moderate Acne on Face and Trunk

Phase: N/A Priority: Normal
NCT ID: NCT06463925 Org: User:
Start: 12/07/23 End: 09/30/24 Due: 09/30/25